Curanex Pharmaceuticals (NASDAQ:CURX) Share Price Breaks Below 50-Day Moving Average – Time to Sell?

Curanex Pharmaceuticals Inc (NASDAQ:CURX) shares crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $4.94 and traded as low as $4.59. Curanex Pharmaceuticals shares last traded at $4.8340, with a volume of 6,252 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Curanex Pharmaceuticals in a research report on Tuesday, October 27th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has an average rating of “Sell”.

Curanex Pharmaceuticals Stock Down 14.7%

The company’s 50-day moving average is $4.94 and its two-hundred day moving average is $6.09. The company has a market capitalization of $7.59 million, a P/E ratio of -0.62 and a beta of -2.99.

Curanex Pharmaceuticals (NASDAQ:CURX) last announced its earnings results on Friday, November 13th. The company reported ($1.86) earnings per share (EPS) for the quarter.

Curanex Pharmaceuticals Company Profile

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.